XALUD THERAPEUTICS
Xalud Therapeutics is a biotech company that develops therapies for the treatment of neuro-inflammatory diseases. It offers a gene therapy platform that addresses chronic pain. The lead product candidate, XT-150 is in two P2 clinical studies for the treatment of Osteoarthritis Pain. Xalud is a portfolio company of PBM Capital Group. The company was established in 2009 and is based in San Francisco, California, United States.
XALUD THERAPEUTICS
Industry:
Biotechnology Health Care Medical Neuroscience Therapeutics
Founded:
2009-01-01
Address:
New York, New York, United States
Country:
United States
Website Url:
http://www.xaludthera.com
Total Employee:
11+
Status:
Active
Contact:
(434) 980-8105
Total Funding:
42.3 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Apple Mobile Web Clips Icon Content Delivery Network Euro Microsoft Exchange Online Office 365 Mail Microsoft Azure DNS
Similar Organizations
Affimed
Affimed Therapeutics is focused on developing recombinant antibody therapeutics for the treatment of cancer and other diseases.
Anteros Pharmaceuticals
Anteros Pharmaceuticals is a biotechnology company that develops drugs for fibrotic and other inflammatory diseases.
Rakuten Medical
Rakuten Medical is a Bio-technology Company.
AZTherapies
AZTherapies is a clinical stage biotech company developing breakthrough treatments for neuroinflammation-related diseases.
Cedilla Therapeutics
Cedilla Therapeutics is a biotechnology company that develops targeted small molecules for the treatment of cancer and other diseases.
Q32 Bio
Q32 Bio is a biotechnology company that develops treatments for patients with severe autoimmune and inflammatory diseases.
Current Advisors List
Current Employees Featured
Founder
Investors List
PBM Capital Group
PBM Capital Group investment in Series C - Xalud Therapeutics
Key Employee Changes
| Date | New article |
|---|---|
| 2021-11-09 | Xalud Therapeutics Appoints Charles Triano as Chief Financial Officer |
Official Site Inspections
http://www.xaludthera.com
- Host name: 147.62.236.23.bc.googleusercontent.com
- IP address: 23.236.62.147
- Location: Mountain View United States
- Latitude: 37.4043
- Longitude: -122.0748
- Metro Code: 807
- Timezone: America/Los_Angeles
- Postal: 94043
More informations about "Xalud Therapeutics"
ABOUT | Xalud - xaludthera.com
At Xalud Therapeutics, we are driven to discover, develop and provide novel treatments for chronic inflammatory diseases that can dramatically improve the health and quality of life for …See details»
CONTACT - Xalud
Partnering At Xalud, we are open to collaborating with future partners to help realize our mission of alleviating the high disease burden on patient lives and large treatment costs for the …See details»
Xalud Therapeutics, Inc. Management Team | Org Chart
Xalud Therapeutics, Inc. Management Xalud Therapeutics, Inc. employs 21 employees. The Xalud Therapeutics, Inc. management team includes Diem Nguyen (Chief Executive Officer), …See details»
Xalud Therapeutics - Crunchbase Company Profile
Xalud Therapeutics is a biotech company that develops therapies for the treatment of neuro-inflammatory diseases.See details»
Xalud Therapeutics 2025 Company Profile: Valuation, …
Information on valuation, funding, cap tables, investors, and executives for Xalud Therapeutics. Use the PitchBook Platform to explore the full profile.See details»
XALUD THERAPEUTICS, INC. - VentureRadar
Xalud Therapeutics is a biotechnology company developing a DNA-delivered therapy platform to treat pathologic inflammation through immune modulation. Xalud is harnessing the power of …See details»
Xalud Therapeutics, Inc. (Xalud Therapeutics, Inc.) - 药物管线_专 …
Prior to Xalud, Dr. Nguyen served as executive vice president of biopharma at PPD Inc., a leading global clinical research organization providing integrated drug development services.See details»
Xalud Therapeutics, Inc. - Drug pipelines, Patents, Clinical trials ...
May 3, 2023 Explore Xalud Therapeutics, Inc. with its drug pipeline, therapeutic area, technology platform, 7 clinical trials, 17 news, Disease Domain:Endocrinology and Metabolic ...See details»
Xalud Therapeutics Company Profile - Office Locations ... - Craft
Xalud Therapeutics $12.3 m in total funding,. See insights on Xalud Therapeutics including office locations, competitors, revenue, financials, executives, subsidiaries and more at Craft.See details»
Xalud Therapeutics, Inc. Information - RocketReach
Xalud Therapeutics, Inc. is a Biotechnology, Medical Testing & Clinical Laboratories, and Health Care company located in New York, New York with $608000 in revenue and 15 employees. …See details»
PIPELINE - Xalud
In order to treat inflammatory diseases in an effective, safe, long-lasting, and disease-modifying manner, patients require a therapeutic approach that can stop the inflammatory cascade and …See details»
Orphanet: Xalud Therapeutics, Inc.
The documents contained in this website are presented for information purposes only. The material is in no way intended to replace professional medical care by a qualified specialist …See details»
Xalud Therapeutics, Inc. Overview | SignalHire Company Profile
Xalud Therapeutics, Inc. is a private company that has been in the industry for 14 years. The company currently specializes in the Biotechnology, Biotechnology areas. The position of the …See details»
Xalud Therapeutics appoints Dr. Diem Nguyen as CEO
Jan 22, 2021 Dr. Nguyen joins Xalud from PPD, Inc., a leading global clinical research organization providing integrated drug development services, where she served as executive …See details»
XT-150 in Amyotrophic Lateral Sclerosis (ALS) - ICH GCP
Nov 20, 2024 This is a Phase 1, open-label, multi-center safety study of XT-150 in adult participants with Amyotrophic Lateral Sclerosis (ALS). Participants providing informed consent …See details»
PATIENTS - Xalud
We encourage all patients and physicians who are interested in accessing our investigational medicines to review the information on this page about our clinical trials in progress. If you …See details»
xaludthera.com - Xalud Therapeutics | Gene Ther... - Xalud Thera
Xaludthera.com. Xalud Therapeutics is a clinical-stage biotechnology company developing a non-viral gene therapy platform to treat pathologic infl...See details»
Loma Linda University Health is first in Southern California to …
1 day ago Thalassemia patient is regaining strength after the first cell therapy treatment of its kind in Southern California.See details»
SCIENCE - Xalud
Cytokines are proteins that play a critical role in the inflammatory cascade that is part of the healing process. In response to an injury, the acute pro-inflammatory cytokine response lasts …See details»
NEWS | Xalud - Xalud Therapeutics
Dec 17, 2021 Xalud Therapeutics Receives FDA Fast Track Designation for XT-150 for the Treatment of Pain Associated with Osteoarthritis of the Knee NEW YORK, December 17, 2021 …See details»